These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 28193237)

  • 1. Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.
    Ferner RE; Thomas M; Mercer G; Williams V; Leschziner GD; Afridi SK; Golding JF
    Health Qual Life Outcomes; 2017 Feb; 15(1):34. PubMed ID: 28193237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Food-related Quality of Life in Inflammatory Bowel Disease: Development and Validation of a Questionnaire.
    Hughes LD; King L; Morgan M; Ayis S; Direkze N; Lomer MC; Lindsay JO; Whelan K
    J Crohns Colitis; 2016 Feb; 10(2):194-201. PubMed ID: 26507859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study.
    Bicudo NP; Germano CMR; de Moraes RT; de Avó LRDS; Ferner RE; Melo DG
    An Bras Dermatol; 2024; 99(4):520-526. PubMed ID: 38493052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.
    Nutakki K; Hingtgen CM; Monahan P; Varni JW; Swigonski NL
    Health Qual Life Outcomes; 2013 Feb; 11():21. PubMed ID: 23432799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the childhood asthma questionnaire a good measure of health-related quality of life of asthmatic children in Asia?: validation among paediatric patients with asthma in Singapore.
    Chong LY; Chay OM; Shu-Chuen L
    Pharmacoeconomics; 2006; 24(6):609-21. PubMed ID: 16761907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1.
    Dance B; Dardare A; Fleming J; Siow SF; Schlub TE; Crawford H; Saunderson RB; Wong C; Berman Y
    J Dermatol; 2024 Aug; 51(8):1050-1059. PubMed ID: 38923593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-cultural Adaptation and Validation of the Stoma Quality of Life Questionnaire for Patients With a Colostomy or Ileostomy in Brazil: A Cross-sectional Study.
    Lívia de Oliveira A; Loures Mendes L; Pereira Netto M; Gonçalves Leite IC
    Ostomy Wound Manage; 2017 May; 63(5):34-41. PubMed ID: 28570247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development and validation of the Cluster Headache Quality of life scale (CHQ).
    Abu Bakar N; Torkamani M; Tanprawate S; Lambru G; Matharu M; Jahanshahi M
    J Headache Pain; 2016 Dec; 17(1):79. PubMed ID: 27596922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NFTI-QOL: A Disease-Specific Quality of Life Questionnaire for Neurofibromatosis 2.
    Hornigold RE; Golding JF; Leschziner G; Obholzer R; Gleeson MJ; Thomas N; Walsh D; Saeed S; Ferner RE
    J Neurol Surg B Skull Base; 2012 Apr; 73(2):104-11. PubMed ID: 23543835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric Validation of the Heart Failure Caregiver Questionnaire (HF-CQ
    Strömberg A; Bonner N; Grant L; Bennett B; Chung ML; Jaarsma T; Luttik ML; Lewis EF; Calado F; Deschaseaux C
    Patient; 2017 Oct; 10(5):579-592. PubMed ID: 28343292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The CVID_QoL Questionnaire.
    Quinti I; Pulvirenti F; Giannantoni P; Hajjar J; Canter DL; Milito C; Abeni D; Orange JS; Tabolli S
    J Allergy Clin Immunol Pract; 2016; 4(6):1169-1179.e4. PubMed ID: 27665385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases.
    Wolkenstein P; Rodriguez D; Ferkal S; Gravier H; Buret V; Algans N; Simeoni MC; Bastuji-Garin S
    Br J Dermatol; 2009 Apr; 160(4):844-8. PubMed ID: 19067713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appraisal of a specific scale for quality of life (AlQoL-9) in Greek alcohol dependent individuals attending: A confirmatory factor analysis.
    Pappa AS; Ginieri-Coccossis M; Richardson C; Charalampi A; Liappas IA; Paparrigopoulos T
    Psychiatriki; 2016; 27(1):17-26. PubMed ID: 27110879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2.
    Ferner RE; Shaw A; Evans DG; McAleer D; Halliday D; Parry A; Raymond FL; Durie-Gair J; Hanemann CO; Hornigold R; Axon P; Golding JF
    J Neurol; 2014 May; 261(5):963-9. PubMed ID: 24619350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study.
    Bishnoi A; Manjunath S; Kishore K; De D; Handa S; Murrell DF; Mahajan R
    Indian J Dermatol Venereol Leprol; 2022; 88(2):177-183. PubMed ID: 34491666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and preliminary evaluation of the Neurofibromatosis Type 1 Adult Quality of Life (NF1-AdQoL) questionnaire.
    Crawford H; North K; Wilson MJ; Berman Y; McKelvey-Martin V; Morrison PJ; Fleming J; Barton B
    Clin Exp Dermatol; 2022 Feb; 47(2):271-281. PubMed ID: 34342021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turkish version of the Johns Hopkins Restless Legs Syndrome Quality of Life Questionnaire (RLS-QoL): validity and reliability study.
    Güler S; Nesrin Turan F
    Qual Life Res; 2015 Nov; 24(11):2789-94. PubMed ID: 25999305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional coping is related to impaired skin-related quality of life and psychological distress in patients with neurofibromatosis type 1 with major skin involvement.
    Bottesi G; Spoto A; Trevisson E; Zuccarello D; Vidotto G; Cassina M; Clementi M
    Br J Dermatol; 2020 Jun; 182(6):1449-1457. PubMed ID: 31329288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and Factors of Quality of Life Among Patients With Neurofibromatosis Type 1-Associated Craniofacial Plexiform Neurofibromas.
    Ren JY; Gu YH; Wei CJ; Huang X; Xu XW; Gu B; Zan T; Wang ZC; Li QF
    J Craniofac Surg; 2020; 31(2):347-350. PubMed ID: 31977693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conceptualization, development and validation of T-QoL
    Basra MKA; Salek MS; Fenech D; Finlay AY
    Br J Dermatol; 2018 Jan; 178(1):161-175. PubMed ID: 28762236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.